Terms: = Bone cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
2303 results:
1. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape.
Karel D; Valburg C; Woddor N; Nava VE; Aggarwal A
Curr Oncol; 2024 Apr; 31(4):1971-1993. PubMed ID: 38668051
[TBL] [Abstract] [Full Text] [Related]
2. IFNα-induced BST2
Zheng C; Wang J; Zhou Y; Duan Y; Zheng R; Xie Y; Wei X; Wu J; Shen H; Ye M; Kong B; Liu Y; Xu P; Zhang Q; Liang T
Cell Rep; 2024 Apr; 43(4):114088. PubMed ID: 38602878
[TBL] [Abstract] [Full Text] [Related]
3. [Efficacy and prognostic factors of allogeneic hematopoietic stem cell transplantation in the treatment of secondary acute myeloid leukemia].
Yuan XL; Wu YB; Song XL; Chen Y; Lu Y; Lai XY; Shi JM; Liu LZ; Zhao YM; Yu J; Yang LX; Lan JP; Cai Z; Huang H; Luo Y
Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):41-47. PubMed ID: 38527837
[No Abstract] [Full Text] [Related]
4. Investigation of cellular communication and signaling pathways in tumor microenvironment for high tp53-expressing osteosarcoma cells through single-cell RNA sequencing.
Xiong K; Fang Y; Qiu B; Chen C; Huang N; Liang F; Huang C; Lu T; Zheng L; Zhao J; Zhu B
Med Oncol; 2024 Mar; 41(5):93. PubMed ID: 38526643
[TBL] [Abstract] [Full Text] [Related]
5. HSPA9/mortalin inhibition disrupts erythroid maturation through a tp53-dependent mechanism in human CD34+ hematopoietic progenitor cells.
Butler C; Dunmire M; Choi J; Szalai G; Johnson A; Lei W; Chen X; Liu L; Li W; Walter MJ; Liu T
Cell Stress Chaperones; 2024 Apr; 29(2):300-311. PubMed ID: 38508444
[TBL] [Abstract] [Full Text] [Related]
6. Germline predisposition to myeloid neoplasms: Characteristics and management of high versus variable penetrance disorders.
Trottier AM; Feurstein S; Godley LA
Best Pract Res Clin Haematol; 2024 Mar; 37(1):101537. PubMed ID: 38490765
[TBL] [Abstract] [Full Text] [Related]
7. Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid Leukemia.
Cieniewicz B; Oliveira E; Saxton M; Torabi D; Bhatta A; Kukutla P; Arballo A; Yang Z; Yu B; Fate M; Ning H; Corey L; Maiti A; Corey D
Clin Cancer Res; 2024 May; 30(9):1878-1888. PubMed ID: 38451195
[TBL] [Abstract] [Full Text] [Related]
8. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract] [Full Text] [Related]
9. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study.
Zheng J; Wang T; Yang Y; Huang J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Selvaggi G; Wang Y; Xiao S; Wang Q; Shen Z; Zhou J; Zhou J; Zhang L
Cancer Commun (Lond); 2024 Apr; 44(4):455-468. PubMed ID: 38421881
[TBL] [Abstract] [Full Text] [Related]
10. tp53 in MDS and AML: Biological and clinical advances.
Zhao Y; Chen W; Yu J; Pei S; Zhang Q; Shi J; Huang H; Zhao Y
Cancer Lett; 2024 Apr; 588():216767. PubMed ID: 38417666
[TBL] [Abstract] [Full Text] [Related]
11. Targeted inhibition of SCF
Wang J; Ferrena A; Zhang R; Singh S; Viscarret V; Al-Harden W; Aldahamsheh O; Borjihan H; Singla A; Yaguare S; Tingling J; Zi X; Lo Y; Gorlick R; Schwartz EL; Zhao H; Yang R; Geller DS; Zheng D; Hoang BH
Oncogene; 2024 Mar; 43(13):962-975. PubMed ID: 38355807
[TBL] [Abstract] [Full Text] [Related]
12. Immunohistochemistry screening for tp53 mutation in myeloid neoplasms in AZF-fixed bone marrow biopsies.
Yang G; Anderson Williams S; He F; He Y; McIntyre K; Beckman AK; Nelson AC; Yohe SL
Pathology; 2024 Apr; 56(3):404-412. PubMed ID: 38341302
[TBL] [Abstract] [Full Text] [Related]
13. A Missense Variant in
Usategui-Martín R; Galindo-Cabello N; Pastor-Idoate S; Fernández-Gómez JM; Del Real Á; Ferreño D; Lapresa R; Martín-Rodriguez F; Riancho JA; Almeida Á; Pérez-Castrillón JL
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338673
[TBL] [Abstract] [Full Text] [Related]
14. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
15. WT1 and tp53 as valuable diagnostic biomarkers for relapse after hematopoietic stem cell transplantation in acute myeloid leukemia.
Asghari-Ghomi A; Fallahian F; Garavand J; Mohammadi MH
Mol Biol Rep; 2024 Feb; 51(1):244. PubMed ID: 38300383
[TBL] [Abstract] [Full Text] [Related]
16. Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications.
Bruzzese A; Martino EA; Mendicino F; Lucia E; Olivito V; Capodanno I; Neri A; Morabito F; Vigna E; Gentile M
Eur J Haematol; 2024 Jun; 112(6):860-869. PubMed ID: 38294126
[TBL] [Abstract] [Full Text] [Related]
17. Regulation of the p53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.
Akbari P; Taebpour M; Akhlaghi M; Hasan SH; Shahriyari S; Parsaeian M; Haghirosadat BF; Rahdar A; Pandey S
Med Oncol; 2024 Jan; 41(3):68. PubMed ID: 38289404
[TBL] [Abstract] [Full Text] [Related]
18. [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion].
Wang WN; Liu XT; Liang YM
Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
[No Abstract] [Full Text] [Related]
19. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract] [Full Text] [Related]
20. Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease.
Yin C; Li Y; Zhang C; Zang S; Wang Z; Yan X; Ma T; Li X; Li W
BMC Cancer; 2024 Jan; 24(1):111. PubMed ID: 38254070
[TBL] [Abstract] [Full Text] [Related]
[Next]
